Ariad Pharm Inc (ARIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2007 | 09-2007 | 06-2007 | 03-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -58,522 | -42,806 | -31,956 | -14,951 | -61,928 |
| Depreciation Amortization | 1,509 | 1,156 | 755 | 451 | 3,006 |
| Accounts payable and accrued liabilities | 1,046 | -1,900 | 1,397 | -384 | 42 |
| Other Working Capital | 84,057 | 70,343 | 1,130 | 358 | -2,563 |
| Other Operating Activity | 5,898 | 7,132 | 2,307 | 1,889 | 5,405 |
| Operating Cash Flow | $33,988 | $33,925 | $-26,367 | $-12,637 | $-56,038 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -8,460 | -8,539 | -11,461 | -6,931 | 49,642 |
| PPE Investments | -1,346 | -725 | -294 | -80 | -1,067 |
| Purchase Sale Intangibles | -497 | -371 | -299 | -200 | -568 |
| Other Investing Activity | -868 | -371 | -299 | -200 | -568 |
| Investing Cash Flow | $-10,674 | $-9,635 | $-12,054 | $-7,211 | $48,007 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,920 | -1,440 | -960 | -480 | -1,920 |
| Common Stock Issued | 14,371 | 14,297 | 13,420 | 12,547 | 16,226 |
| Financing Cash Flow | $12,451 | $12,857 | $12,460 | $12,067 | $14,306 |
| Beginning Cash Position | 31,400 | 31,728 | 31,728 | 31,728 | 25,453 |
| End Cash Position | 67,165 | 68,875 | 5,767 | 23,947 | 31,728 |
| Net Cash Flow | $35,765 | $37,147 | $-25,961 | $-7,781 | $6,275 |
| Free Cash Flow | |||||
| Operating Cash Flow | 33,988 | 33,925 | -26,367 | -12,637 | -56,038 |
| Capital Expenditure | -1,346 | -725 | -294 | -80 | -1,067 |
| Free Cash Flow | 32,642 | 33,200 | -26,661 | -12,717 | -57,105 |